PMID- 30017878 OWN - NLM STAT- MEDLINE DCOM- 20190805 LR - 20190905 IS - 1525-0024 (Electronic) IS - 1525-0016 (Print) IS - 1525-0016 (Linking) VI - 26 IP - 9 DP - 2018 Sep 5 TI - Extracellular Vesicles Containing IL-4 Modulate Neuroinflammation in a Mouse Model of Multiple Sclerosis. PG - 2107-2118 LID - S1525-0016(18)30310-1 [pii] LID - 10.1016/j.ymthe.2018.06.024 [doi] AB - Extracellular vesicles (EVs) play a major role in cell-to-cell communication in physiological and pathological conditions, and their manipulation may represent a promising therapeutic strategy. Microglia, the parenchymal mononuclear phagocytes of the brain, modulate neighboring cells also through the release of EVs. The production of custom EVs filled with desired molecules, possibly targeted to make their uptake cell specific, and their administration in biological fluids may represent a valid approach for drug delivery. We engineered a murine microglia cell line, BV-2, to release EVs overexpressing the endogenous "eat me" signal Lactadherin (Mfg-e8) on the surface to target phagocytes and containing the anti-inflammatory cytokine IL-4. A single injection of 10(7) IL-4(+)Mfg-e8(+) EVs into the cisterna magna modulated established neuroinflammation and significantly reduced clinical signs in the mouse model of multiple sclerosis, experimental autoimmune encephalomyelitis (EAE). Injected IL-4(+)Mfg-e8(+) EVs target mainly phagocytes (i.e., macrophages and microglia) surrounding liquoral spaces, and their cargo promote the upregulation of anti-inflammatory markers chitinase 3-like 3 (ym1) and arginase-1 (arg1), significantly reducing tissue damage. Engineered EVs may represent a biological drug delivery tool able to deliver multiple functional molecules simultaneously to treat neuroinflammatory diseases. CI - Copyright (c) 2018 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved. FAU - Casella, Giacomo AU - Casella G AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Colombo, Federico AU - Colombo F AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Finardi, Annamaria AU - Finardi A AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Descamps, Helene AU - Descamps H AD - Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Ill-Raga, Gerard AU - Ill-Raga G AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Spinelli, Antonello AU - Spinelli A AD - Experimental Imaging Centre, San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Podini, Paola AU - Podini P AD - Department of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Bastoni, Mattia AU - Bastoni M AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Martino, Gianvito AU - Martino G AD - Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Muzio, Luca AU - Muzio L AD - Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology, San Raffaele Scientific Institute, 20132 Milan, Italy. FAU - Furlan, Roberto AU - Furlan R AD - Clinical Neuroimmunology Unit, Department of Neuroscience, Institute of Experimental Neurology (InSpe), San Raffaele Scientific Institute, 20132 Milan, Italy. Electronic address: furlan.roberto@hsr.it. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180705 PL - United States TA - Mol Ther JT - Molecular therapy : the journal of the American Society of Gene Therapy JID - 100890581 RN - 0 (CD11b Antigen) RN - 207137-56-2 (Interleukin-4) MH - Animals MH - CD11b Antigen/metabolism MH - CD4-Positive T-Lymphocytes/metabolism/ultrastructure MH - Cell Line MH - Cells, Cultured MH - Disease Models, Animal MH - Extracellular Vesicles/*metabolism/ultrastructure MH - Female MH - Interleukin-4/*metabolism MH - Macrophages/metabolism/ultrastructure MH - Mice MH - Mice, Inbred C57BL MH - Microscopy, Electron, Transmission MH - Microscopy, Fluorescence MH - Multiple Sclerosis/*metabolism MH - Rats MH - Reverse Transcriptase Polymerase Chain Reaction PMC - PMC6127510 OTO - NOTNLM OT - extracellular vesicles OT - neuroinflammation OT - phagocytes EDAT- 2018/07/19 06:00 MHDA- 2019/08/06 06:00 PMCR- 2019/09/05 CRDT- 2018/07/19 06:00 PHST- 2018/03/20 00:00 [received] PHST- 2018/06/22 00:00 [revised] PHST- 2018/06/25 00:00 [accepted] PHST- 2018/07/19 06:00 [pubmed] PHST- 2019/08/06 06:00 [medline] PHST- 2018/07/19 06:00 [entrez] PHST- 2019/09/05 00:00 [pmc-release] AID - S1525-0016(18)30310-1 [pii] AID - 10.1016/j.ymthe.2018.06.024 [doi] PST - ppublish SO - Mol Ther. 2018 Sep 5;26(9):2107-2118. doi: 10.1016/j.ymthe.2018.06.024. Epub 2018 Jul 5.